mortality/aging
• decreased survival with 50% lethality at 15 months
|
• decreased survival with 50% lethality at 15 months
|
immune system
• cells proliferate earlier in response to mitogenic stimulation based upon CFSE labeling
|
• monoclonal B cell lymphocytosis in about 5% of mice
|
• increased number of poly/oligoclonal cells in the peritoneal cavity at 12 months
• at 15-18 months, increased clonal population in the peripheral blood
|
• expansion or accumulation of small lymphocytes, with a pattern similar small cell lymphocytic leukemia (SLL) or B cell chronic lymphocytic leukemia (CLL) and with characteristic 'smudge' cells in some mice
|
neoplasm
• a fraction of mice have histological features of small cell lymphocytic leukemia (SLL) or B cell chronic lymphocytic leukemia (CLL)
|
• some of the CD5 negative tumors showed a mature B cell phenotype histologically reminiscent of human diffuse large B cell lymphoma, non-Hodgkin lymphoma
• a minority of CD5 negative tumors showed plasmacytic features similar to lymphoplasmacytic
lymphoma
|
hematopoietic system
• cells proliferate earlier in response to mitogenic stimulation based upon CFSE labeling
|
• monoclonal B cell lymphocytosis in about 5% of mice
|
• increased number of poly/oligoclonal cells in the peritoneal cavity at 12 months
• at 15-18 months, increased clonal population in the peripheral blood
|
• expansion or accumulation of small lymphocytes, with a pattern similar small cell lymphocytic leukemia (SLL) or B cell chronic lymphocytic leukemia (CLL) and with characteristic 'smudge' cells in some mice
|
cellular
• cells proliferate earlier in response to mitogenic stimulation based upon CFSE labeling
|
Mouse Models of Human Disease |
DO ID | OMIM ID(s) | Ref(s) | |
chronic lymphocytic leukemia | DOID:1040 |
OMIM:109543 OMIM:151400 OMIM:609630 OMIM:612557 OMIM:612558 OMIM:612559 |
J:156946 |